TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
SVAR Life Science AB
Closing information (x1000 SEK)
Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover | 265,788 | 221,893 | 206,371 |
Financial expenses | 8,098 | 6,878 | 13,469 |
Earnings before taxes | 45,257 | -35,197 | -7,544 |
EBITDA | 47,780 | 38,772 | -4,088 |
Total assets | 279,773 | 243,633 | 288,143 |
Current assets | 173,991 | 102,893 | 88,355 |
Current liabilities | 58,735 | 51,694 | 61,295 |
Equity capital | 194,672 | 150,730 | 172,012 |
- share capital | 293 | 293 | 293 |
Employees (average) | 120 | 123 | 90 |
Financial ratios
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency | 69.6% | 61.9% | 59.7% |
Turnover per employee | 2,215 | 1,804 | 2,293 |
Profit as a percentage of turnover | 17.0% | -15.9% | -3.7% |
Return on assets (ROA) | 19.1% | -11.6% | 2.1% |
Current ratio | 296.2% | 199.0% | 144.1% |
Return on equity (ROE) | 23.2% | -23.4% | -4.4% |
Change turnover | 43,895 | 15,522 | -46,132 |
Change turnover % | 20% | 8% | -18% |
Chg. No. of employees | -3 | 33 | -40 |
Chg. No. of employees % | -2% | 37% | -31% |
Total value of public sale
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.